Key Developments For PDI Inc
PDI Inc (PDII.O) (Consolidated Issue listed on NASDAQ Global Market)
PDI, Inc. and Physicians Interactive Partner To Provide Integrated, Personal And Digital Solutions To Life Sciences Companies
PDI, Inc. and Physicians Interactive, the provider of mobile reference and digital sales and marketing services to life sciences companies, announced that they have entered into a strategic alliance to collaborate and deliver the first integrated network of digital sales and marketing solutions. These products will drive expanded reach and revenue for life sciences customers, while increasing the level of service, access and value to physicians. By way of this unique collaboration, life sciences companies will be able to provide a comprehensive, optimized mix of personal delivery services, such as PDI's field sales, peer based, and call center services to physicians who benefit from physical outreach. Physicians Interactive will augment PDI's personal efforts, and extend services to those physicians challenged by location, time, or preference with an exciting range of on demand digital services. These offerings include leading mobile based point of care decision support tools, electronic sampling and patient assistance programs, as well as interactive online education.
PDI, Inc. Announces New Business Wins Exceeding $18 Million
PDI, Inc. announced new business wins with four pharmaceutical and medical device companies. These four engagements are expected to contribute approximately $9 million in combined revenue in 2009, and three of the contracts are expected to contribute nearly $10 million in revenue in 2010. The contracts include several different types of PDI's sales team offerings in the primary care, specialty and hospital settings. Sales representatives will be deployed in June for all four engagements, and they will be calling on office and hospital-based physicians specializing in women's health, primary care and pediatrics.
PDI, Inc. and The Medical Affairs Company Enter Exclusive Strategic Alliance
PDI, Inc. and The Medical Affairs Company (TMAC), the provider of customized Medical Science Liaison (MSL) and Medical Affairs services, announced that they have signed an agreement aligning their respective services in order to bring clients a more complete set of field-based commercialization solutions. Under the exclusive agreement, PDI and TMAC will integrate their service offerings to benefit client brands, participate in joint client presentations and exchange new business leads.
PDI, Inc. Announces Termination of Promotion Agreement
PDI, Inc. announced that PDI and Novartis have agreed to terminate a promotion agreement that was entered into in April 2008 under PDI's product commercialization initiative whereby PDI deployed a sales field force and provided other promotional activities to promote a Novartis branded product in the United States. PDI discontinued all promotional activities related to the product effective as of April 22, 2009. In connection with the termination of this agreement, Novartis will receive credits for services that PDI is currently providing to Novartis under a fee for service sales force agreement for another Novartis branded product.
Sequenom Selects PDI, Inc. To Provide Sales Team For Launch of Noninvasive Prenatal Screening Tests
PDI, Inc. and Sequenom Center for Molecular Medicine, LLC (SCMM), a wholly owned subsidiary of Sequenom, Inc. announced that PDI has been selected to provide the sales infrastructure to launch and commercialize SCMM's noninvasive prenatal genetic screening tests based on its SEQureDx technology. Under the direction of SCMM management, PDI will support the commercialization of SCMM`s fetal Rhesus D genotyping test from a maternal blood sample. This test will reduce the risk to the mother and fetus by providing clinicians early and accurate information. Under the agreement, PDI will also provide sales support to SCMM upon commercialization of its noninvasive Down syndrome (Trisomy 21) test which is expected to be launched in June of this year, as well as other laboratory developed tests.
